Showing results (251-260 of 337) with videos related to
Sort By:
Pageof 34
Tissue Antigens|August 1, 1993
Analysis of HLA-DQA1 and -DQB1 genes in Mexican Americans with insulin-dependent diabetes mellitusC B Sanjeevi, A Zeidler, S Shaw, et al.Current Drug Metabolism|December 30, 2010
Targeting intestinal transporters for optimizing oral drug absorptionManthena V Varma, Catherine M Ambler, Mohammad Ullah, et al.Molecules (Basel, Switzerland)|February 25, 2023
Integrating Siderophore Substructures in Thiol-Based Metallo-β-Lactamase InhibitorsMarco J Rotter, Sabrina Zentgraf, Lilia Weizel, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 19, 2016
The Antimicrobial Agent Fusidic Acid Inhibits Organic Anion Transporting Polypeptide-Mediated Hepatic Clearance and May Potentiate Statin-Induced MyopathyHeather Eng, Renato J Scialis, Charles J Rotter, et al.American Journal of Human Genetics|May 12, 2001
The molecular basis of X-linked spondyloepiphyseal dysplasia tardaA K Gedeon, G E Tiller, M Le Merrer, et al.Molecular Pharmaceutics|June 30, 2011
pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1Manthena V Varma, Charles J Rotter, Jonathan Chupka, et al.Nature Genetics|March 18, 1999
Heterozygous mutations in the gene encoding noggin affect human joint morphogenesisY Gong, D Krakow, J Marcelino, et al.American Journal of Human Genetics|April 16, 1998
Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrumM D Briggs, G R Mortier, W G Cole, et al.Journal of Medical Genetics|September 13, 2005
The phenotypic spectrum in patients with arginine to cysteine mutations in the COL2A1 geneK P Hoornaert, C Dewinter, I Vereecke, et al.European Journal of Medicinal Chemistry|December 6, 2021
Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamasesAnna Proschak, Giada Martinelli, Denia Frank, et al.Pageof 34